EYEPOINT PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.69 EUR | -3.34% |
|
-4.06% | -54.29% |
| 05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
| 05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 28/05/2024 | 29/05/2024 | 30/05/2024 | 31/05/2024 | |
|---|---|---|---|---|
| Last | 10.11 € | 9.93 € | 10.025 € | 9.69 € |
| Volume | 0 | 0 | 0 | 0 |
| Change | -3.58% | -1.78% | +0.96% | -3.34% |
| Opening | 10.17 | 10.05 | 9.88 | 9.74 |
| High | 10.17 | 10.06 | 10.03 | 9.74 |
| Low | 10.11 | 9.93 | 9.88 | 9.69 |
Performance
| 1 day | -3.34% | ||
| 1 week | -4.06% | ||
| 1 month | -49.39% | ||
| 3 months | -60.93% | ||
| 6 months | +71.50% | ||
| Current year | -54.29% | ||
| 1 year | +73.04% | ||
| 3 years | +21.12% | ||
| 5 years | -32.05% | ||
| 10 years | -63.83% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
557 823 656
Capitalization (USD)
557 823 656
Net sales (USD)
46 018 000
Number of employees
121
Sales / Employee (USD)
380 314
Free-Float
97.46 %
Free-Float capitalization (EUR)
589 587 135
Free-Float capitalization (USD)
543 648 864
Average Daily Capital Traded
0%
Highs and lows
1 week
9.69
10.49
1 month
9.6918.46
Current year
9.6928.60
1 year
5.2528.60
3 years
2.0828.60
5 years
0.3828.60
10 years
0.3850.00
Indicators
Moving average 5 days
10.05
Moving average 20 days
11.94
Moving average 50 days
16.88
Moving average 100 days
19.83
Price spread / (MMA5)
+3.69%
Price spread / (MMA20)
+23.21%
Price spread / (MMA50)
+74.25%
Price spread / (MMA100)
+104.69%
STIM
RSI 9 days
27.13
RSI 14 days
28.30
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -3.34% | -4.06% | -54.29% | +73.04% | 558M | ||
| +0.65% | +1.60% | +40.73% | +87.94% | 739B | ||
| +1.13% | -0.16% | +32.83% | +68.81% | 598B | ||
| +1.09% | -0.07% | -6.30% | -4.97% | 353B | ||
| +0.81% | -3.05% | +15.15% | +13.17% | 318B | ||
| +3.15% | +2.66% | +4.05% | +20.83% | 285B | ||
| +1.35% | -0.86% | +15.00% | +4.46% | 240B | ||
| +2.13% | +1.56% | +9.78% | +5.80% | 210B | ||
| +1.18% | +0.26% | -5.52% | -20.28% | 206B | ||
| +1.59% | -0.01% | +6.17% | +42.72% | 164B | ||
| +1.63% | -0.76% | -0.45% | -24.62% | 162B | ||
| +1.34% | +0.27% | -.--% | -4.72% | 122B | ||
| +2.11% | -0.45% | +21.81% | +31.08% | 91.66B | ||
| +2.17% | -0.28% | -19.85% | -36.42% | 83.29B | ||
| +3.32% | +2.46% | +44.06% | +20.27% | 68.01B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +1.27% | +0.33% | +6.88% | +18.47% | ||
| Weighted average by Cap. | +1.35% | +0.31% | +17.09% | +31.93% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -54.29% | ||
| 2023 | +558.39% | ||
| 2022 | -70.99% | ||
| 2021 | +151.70% | ||
| 2020 | -66.59% | ||
| 2019 | -12.00% | ||
| 2018 | +73.81% | ||
| 2017 | -45.03% | ||
| 2016 | -64.99% | ||
| 2015 | +31.60% | ||
| 2014 | +19.70% | ||
| 2013 | +195.95% | ||
| 2012 | +14.12% | ||
| 2011 | -77.16% | ||
| 2010 | +38.24% | ||
| 2009 | +316.54% | ||
| 2008 | -72.13% |
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- Quotes EyePoint Pharmaceuticals, Inc.
